Literature DB >> 27830073

A case of severe arthralgia with malignant mesothelioma-associated hypertrophic osteoarthropathy.

Hideaki Yamakawa1, Akimasa Sekine2, Terufumi Kato2, Yumie Yamanaka1, Eri Hagiwara2, Shigeaki Umeda3, Takashi Ogura2.   

Abstract

Hypertrophic osteoarthropathy (HOA) is a rare syndrome characterized by the abnormal proliferation of dermato-osseous tissue. We report a rare case of malignant mesothelioma-associated HOA who suffered from refractory painful osteoarthropathy. HOA can be associated with malignant mesothelioma and that may be resistant to any treatment.

Entities:  

Keywords:  Growth hormone; hypertrophic osteoarthropathy; malignant mesothelioma; vascular endothelial growth factor

Year:  2016        PMID: 27830073      PMCID: PMC5093163          DOI: 10.1002/ccr3.709

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


Introduction

Malignant pleural mesothelioma is rare disease, but patients with asbestos‐related mesothelioma have increased in numbers over the last few decades 1. Hypertrophic osteoarthropathy (HOA) is characterized by the coexistence of digital clubbing and periosteal proliferation of the tubular bones. Most cases of HOA associated with pulmonary lesions are lung cancers 2. Some patients complain of a burning sensation in the fingertips and may also suffer from excruciating bone pain 3, 4. Herein, we describe a rare case of malignant pleural mesothelioma‐associated HOA in a febrile patient who suffered from refractory and painful osteoarthropathy.

Case Report

A 67‐year‐old man who was a current smoker (0.5 pack/day for 40 years) had a history of asbestos exposure due to his 4‐year employment as a miner during his twenties. He presented to a local hospital with complaints of productive cough, fever, and right chest pain. On examination, his chest X‐ray and computed tomography (CT) scan revealed right pleural effusion, and his serum C‐reactive protein (CRP) level was elevated. He was diagnosed as having bacterial pleurisy and was then repeatedly treated with antimicrobial agents, twice as an inpatient and twice in an outpatient clinic. However, the antimicrobial therapy was ineffective and remission and exacerbation of his symptoms and CRP level occurred repeatedly over a 3‐month period of therapy. In addition, he presented with dull pain of both wrists 1 month ago. Because of suspicion of having chronic empyema, he was referred to our hospital. Our examination revealed clubbing of the fingers of both hands, particularly the thumbs and forefingers, along with increased pain in the finger, wrist, and shoulder joints. A CT scan revealed right pleural effusion, irregular pleural thickening, mediastinal lymph node swelling, and passive atelectasis (Fig. 1). Analysis of the pleural aspirate could not be performed because of the strongly coagulated pleural effusion. Histological examination of the specimen taken from thoracoscopic pleural biopsy revealed diffuse proliferating malignant cells with eosinophilic cytoplasm as the epithelial formation. The immunohistochemical analysis showed positive staining for calretinin, cytokeratin 5/6, and epithelial membrane antigen and negative staining for TTF‐1, desmin, D2‐40, vimentin, CEA, and CD34 (Fig. 2A–D). These results confirmed the diagnosis of epithelioid‐type malignant pleural mesothelioma. Extrapleuropulmonary metastatic lesions were absent. Moreover, bone scintigraphy showed the bilateral accumulation of 99mTc‐MDP in the wrist, shoulder, and knee joints (Fig. 3A). An 18F‐fluorodeoxyglucose (FDG)‐PET/CT scan showed FDG accumulation in the right pleural lesion, right hilar lymph node, and mediastinal lymph node. Additionally, ring‐shaped accumulations were shown in both wrists and the right shoulder joint (Fig. 3B). These findings, that is, clubbing of the fingers, joint pain, and the bone scintigraphy results, were consistent with secondary HOA of malignant mesothelioma. Additionally, his serum level of growth hormone (GH) was elevated at 1.91 ng/mL, as was his serum level of vascular endothelial growth factor (VEGF) at 411 pg/mL. Immunohistochemical analysis showed positive staining for VEGF in the cytoplasm of the tumor cells (Fig. 2E).
Figure 1

Chest computed tomography images showed right pleural effusion, irregular pleural thickening, mediastinal lymph node swelling, and passive atelectasis.

Figure 2

Histological images. (A) The lesion was characterized by the diffuse proliferation of malignant cells (hematoxylin–eosin stain, ×100). (B) These malignant cells appeared with eosinophilic cytoplasm as the epithelial formation (hematoxylin–eosin stain, ×400). (C) Tumor cells stained positive for calretinin (×400). (D) Tumor cells stained also positive for cytokeratin 5/6 (×400). (E) The cytoplasm of the tumor cells stained positive for VEGF (×400).

Figure 3

(A) Bone scintigraphy scan showed bilateral accumulation of 99mTc‐MDP in the wrist, shoulder, and knee joints. (B) 18F‐fluorodeoxyglucose (FDG)‐PET/CT scan showed FDG accumulation in the right pleural lesion, right hilar lymph node, and mediastinal lymph node. Additionally, ring‐shaped accumulations were present in both wrists and the right shoulder joint.

Chest computed tomography images showed right pleural effusion, irregular pleural thickening, mediastinal lymph node swelling, and passive atelectasis. Histological images. (A) The lesion was characterized by the diffuse proliferation of malignant cells (hematoxylineosin stain, ×100). (B) These malignant cells appeared with eosinophilic cytoplasm as the epithelial formation (hematoxylineosin stain, ×400). (C) Tumor cells stained positive for calretinin (×400). (D) Tumor cells stained also positive for cytokeratin 5/6 (×400). (E) The cytoplasm of the tumor cells stained positive for VEGF (×400). (A) Bone scintigraphy scan showed bilateral accumulation of 99mTc‐MDP in the wrist, shoulder, and knee joints. (B) 18F‐fluorodeoxyglucose (FDG)‐PET/CT scan showed FDG accumulation in the right pleural lesion, right hilar lymph node, and mediastinal lymph node. Additionally, ring‐shaped accumulations were present in both wrists and the right shoulder joint. The patient underwent chemotherapy with cisplatin and pemetrexed. After one cycle, the serum level of GH fell to 0.6 ng/mL. However, his arthralgia and fever did not improve with the administration of nonsteroidal anti‐inflammatory drugs (NSAIDs). Therefore, we initiated oral steroid therapy (betamethasone, 2 mg/day) after the second cycle of chemotherapy. His symptoms slightly improved temporarily, and therefore, the dose of betamethasone was decreased to 1.5 mg/day. Thereafter, however, his arthralgia and fever worsened, and his serum CRP level also rose. After four cycles of chemotherapy, the radiologic response indicated a reduction in the mesothelioma, his disease was considered to be stable, and his serum level of GH had fallen to 0.17 mg/mL. However, his arthralgia and fever continued and worsened when the dose of betamethasone was further decreased. Because our patient was in an extremely weak condition, he was transferred to another hospital to receive palliative treatment as best supportive care, and then died after 9 months at diagnosis as mesothelioma.

Discussion

Hypertrophic osteoarthropathy is a syndrome characterized by abnormal proliferation of the skin and osseous tissues in the distal parts of the extremities. HOA is divided into primary and secondary forms. Primary HOA, also known as pachydermoperiostosis, is a rare heredity condition with variable expressivity. Secondary HOA is most commonly associated with an intrathoracic malignancy, primarily pulmonary malignancies in 80%, including primary and metastatic lung cancer and intrathoracic lymphoma 2, 5. The arthralgia of HOA in the present patient developed during the clinical course of mesothelioma. Bone scintigraphy is a highly sensitive method for the detection of HOA. The typical scintigraphic presentation shows diffuse, symmetrically increased uptake in the diaphysis and metaphysis of tubular bones with a distinctive double stripe or parallel track sign 6. However, although the FDG/PET‐CT scan was to a certain degree a meaningful diagnostic tool in our case, the usefulness of this examination is controversial because the pathogenesis of HOA is not mainly metastasis and inflammation but neogenesis of the periosteum 7. Our patient was diagnosed as having HOA on the basis of the findings of digital clubbing and painful joints and the bone scintigraphy results. In addition, HOA was resistant to conventional treatment with NSAIDS and steroid, although the tumor had shrunk considerably in size with chemotherapy. This case highlights the following clinical implications. First, HOA can develop in patients with malignant mesothelioma. Wierman et al. reported in 1954 that HOA was present in 60% of fibrous tumors of the pleura 8. In their paper, the detailed correlation between malignant mesothelioma and HOA was not described, and immunostaining, which is considered essential to diagnose malignant mesothelioma, was not performed 9. The diagnosis of malignant mesothelioma was immunohistochemically confirmed in our patient. Although the precise rate of occurrence of this condition remains unknown, because the prognosis and survival time of patients with malignant mesothelioma is poor, clinicians might not aware this syndrome for conservative treatment such as opioids, steroid, and NSAIDs. Moreover, there is a highly significant difference between the frequency of digital clubbing in mesothelioma compared with that in benign pleural disease associated with asbestos exposure 10. Careful examination for malignant mesothelioma‐associated HOA should be performed if arthralgia and/or digital clubbing develops in asbestos workers. Second, mechanisms other than GH and VEGF may contribute to the development of mesothelioma‐associated HOA. Generally, the management of HOA is dependent on the underlying disease. Removal of tumors or chemotherapy for cancer can improve or resolve HOA in some cases 5, 11. Pathogenesis of HOA is not fully understood. One hypothesis involves tumor production and the release of factors such as VEGF and GH into the circulation that promote features of HOA 2, 12, 13. However, the considerable reduction in tumor size and decreased serum level of GH with chemotherapy did not improve the severe arthralgia in the present patient. As also VEGF, Kao et al. reported that the median level of serum VEGF in patients with mesothelioma was 564 pg/mL (range: 79–2580 pg/mL), which was higher than the VEGF level in our patient (411 pg/mL) 14. Taken together with these reports, the syndrome in the present case was difficult to explain solely by factors such as GH or VEGF. Although the precise mechanism for this is unclear, we surmise that one of the reason that every kind of cytokine could not be regulated for delay in an appropriate diagnosis and therapy. In conclusion, we describe a rare case of malignant mesothelioma‐associated HOA. To the best of our knowledge, severe symptoms associated with HOA in a patient with malignant mesothelioma have not been previously reported. Although HOA is a rare syndrome whose exact mechanism unknown, careful examination for malignant mesothelioma‐associated HOA should be undertaken if arthralgia and/or digital clubbing develops in asbestos workers.

Conflict of Interest

The authors state that they have no conflict of interests.
  14 in total

1.  Articular manifestations in pulmonary diseases: an analysis of their occurrence in 1,024 cases in which pulmonary resection was performed.

Authors:  W H WIERMAN; O T CLAGETT; J R McDONALD
Journal:  J Am Med Assoc       Date:  1954-08-21

2.  The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.

Authors:  Steven Chuan-Hao Kao; Rozelle Harvie; Florian Paturi; Robyn Taylor; Ross Davey; Rick Abraham; Stephen Clarke; Gavin Marx; Martin Cullen; Zoltan Kerestes; Nick Pavlakis
Journal:  Lung Cancer       Date:  2011-07-16       Impact factor: 5.705

3.  Vascular endothelial growth factor and hypertrophic osteoarthropathy.

Authors:  L H Silveira; M Martínez-Lavín; C Pineda; M C Fonseca; C Navarro; A Nava
Journal:  Clin Exp Rheumatol       Date:  2000 Jan-Feb       Impact factor: 4.473

4.  [A case of pulmonary hypertrophic osteoarthropathy associated with primary lung cancer in a young adult successfully treated with gefitinib].

Authors:  Hisao Imai; Yoshio Tomizawa; Shinichi Ishihara; Noriaki Sunaga; Haruka Aoki; Hironobu Iijima; Yasuki Iwasaki; Satoru Watanabe; Ryusei Saito; Masatomo Mori
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2007-02

5.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Authors:  S Harada; J A Nagy; K A Sullivan; K A Thomas; N Endo; G A Rodan; S B Rodan
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  [A case of lung adenocarcinoma with Marie-Bamberger syndrome that improved by chemotherapy].

Authors:  Yoshitaka Seki; Kenichiro Shimizu; Reiri Onodera; Tethuo Sato; Hisakazu Tai
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2007-04

Review 7.  Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature.

Authors:  Qingping Yao; Roy D Altman; Ernest Brahn
Journal:  Semin Arthritis Rheum       Date:  2008-08-29       Impact factor: 5.532

Review 8.  Hypertrophic osteoarthropathy: what a rheumatologist should know about this uncommon condition.

Authors:  Carlos Pineda; Manuel Martínez-Lavín
Journal:  Rheum Dis Clin North Am       Date:  2013-03-07       Impact factor: 2.670

Review 9.  Diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Francisco Rodríguez Panadero
Journal:  Arch Bronconeumol       Date:  2014-07-22       Impact factor: 4.872

10.  Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure.

Authors:  Takumi Kishimoto; Shinji Ozaki; Katsuya Kato; Hideyuki Nishi; Kenichi Genba
Journal:  Ind Health       Date:  2004-10       Impact factor: 2.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.